Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Q4 2023 Earnings Call Transcript
Accelerate Diagnostics, Inc. misses on earnings expectations. Reported EPS is $-0.89 EPS, expectations were $-0.62. Accelerate Diagnostics, Inc.
Stay updated with breaking news from Accelerate Diagnostics Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Accelerate Diagnostics, Inc. misses on earnings expectations. Reported EPS is $-0.89 EPS, expectations were $-0.62. Accelerate Diagnostics, Inc.
Pune, India, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Microbial identification is the characterization of microbes using a limited spectrum of pre-chosen tests appropriate to the studied problem. Microbial identification
On September 13, 2023, Jack Phillips, the CEO of Accelerate Diagnostics Inc (NASDAQ:AXDX), sold 733 shares of the company.
TUCSON, Ariz. (AP) — TUCSON, Ariz. (AP) — Accelerate Diagnostics Inc. (AXDX) on...
Operator: Good afternoon, and welcome to the Accelerate Diagnostics Fourth Quarter 2022 Earnings Conference Call. Please note, this event is being recorded.